WASHINGTON – The Office of the United States Trade Representative today announced the further extension of the COVID -19 related product exclusions in the China Section 301 Investigation. The exclusions were previously scheduled to expire on May 31, 2022, and will now be extended for an additional six months, through November 30, 2022.
The exclusions cover 81 medical-care products needed to address the COVID-19 pandemic and were initially granted on December 29, 2020. Additional information is set out in the Federal Register notice, which can be viewed here.
###
